Combination Treatment with Lenalidomide-Epoetin Alfa in Low-risk Non-del(5q) MDS: Final Results of the E2905 Intergroup Phase 3 Study

Download Transcript Download Audio

MediCom Worldwide, Inc. Links

ManagingAML.com | ManagingMyeloma.com | ManagingMPN.com | ManagingLymphoma.com | PracticalOncologist.com | PracticalHematologist.com | ManagingCVD.com | ManagingSCD.com | MediComWorldwide.com